These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 21084301)
1. HES1 (hairy and enhancer of split 1) is a determinant of bone mass. Zanotti S; Smerdel-Ramoya A; Canalis E J Biol Chem; 2011 Jan; 286(4):2648-57. PubMed ID: 21084301 [TBL] [Abstract][Full Text] [Related]
2. Hairy and Enhancer of Split-related with YRPW motif (HEY)2 regulates bone remodeling in mice. Zanotti S; Canalis E J Biol Chem; 2013 Jul; 288(30):21547-57. PubMed ID: 23782701 [TBL] [Abstract][Full Text] [Related]
3. Misexpression of CCAAT/enhancer binding protein beta causes osteopenia. Zanotti S; Stadmeyer L; Smerdel-Ramoya A; Durant D; Canalis E J Endocrinol; 2009 May; 201(2):263-74. PubMed ID: 19218285 [TBL] [Abstract][Full Text] [Related]
5. Cooperative functions of Hes/Hey genes in auditory hair cell and supporting cell development. Tateya T; Imayoshi I; Tateya I; Ito J; Kageyama R Dev Biol; 2011 Apr; 352(2):329-40. PubMed ID: 21300049 [TBL] [Abstract][Full Text] [Related]
6. The Notch-responsive transcription factor Hes-1 attenuates osteocalcin promoter activity in osteoblastic cells. Zhang Y; Lian JB; Stein JL; van Wijnen AJ; Stein GS J Cell Biochem; 2009 Oct; 108(3):651-9. PubMed ID: 19670267 [TBL] [Abstract][Full Text] [Related]
7. Connective tissue growth factor is required for skeletal development and postnatal skeletal homeostasis in male mice. Canalis E; Zanotti S; Beamer WG; Economides AN; Smerdel-Ramoya A Endocrinology; 2010 Aug; 151(8):3490-501. PubMed ID: 20534727 [TBL] [Abstract][Full Text] [Related]
8. Hairy and enhancer of split 1 is a primary effector of NOTCH2 signaling and induces osteoclast differentiation and function. Yu J; Schilling L; Eller T; Canalis E J Biol Chem; 2021 Dec; 297(6):101376. PubMed ID: 34742737 [TBL] [Abstract][Full Text] [Related]
9. High bone resorption in adult aging transgenic mice overexpressing cbfa1/runx2 in cells of the osteoblastic lineage. Geoffroy V; Kneissel M; Fournier B; Boyde A; Matthias P Mol Cell Biol; 2002 Sep; 22(17):6222-33. PubMed ID: 12167715 [TBL] [Abstract][Full Text] [Related]
10. HES1 and HES5 are dispensable for cartilage and endochondral bone formation. Karlsson C; Brantsing C; Kageyama R; Lindahl A Cells Tissues Organs; 2010; 192(1):17-27. PubMed ID: 20134146 [TBL] [Abstract][Full Text] [Related]
11. Conditional disruption of Pkd1 in osteoblasts results in osteopenia due to direct impairment of bone formation. Xiao Z; Zhang S; Cao L; Qiu N; David V; Quarles LD J Biol Chem; 2010 Jan; 285(2):1177-87. PubMed ID: 19887454 [TBL] [Abstract][Full Text] [Related]
12. Sustained Notch2 signaling in osteoblasts, but not in osteoclasts, is linked to osteopenia in a mouse model of Hajdu-Cheney syndrome. Zanotti S; Yu J; Sanjay A; Schilling L; Schoenherr C; Economides AN; Canalis E J Biol Chem; 2017 Jul; 292(29):12232-12244. PubMed ID: 28592489 [TBL] [Abstract][Full Text] [Related]
13. Osteoblast lineage-specific effects of notch activation in the skeleton. Canalis E; Parker K; Feng JQ; Zanotti S Endocrinology; 2013 Feb; 154(2):623-34. PubMed ID: 23275471 [TBL] [